StocksFin Logo
Bio-Techne Corporation
Bio-Techne Corporation country of incorporation
|
https://www.bio-techne.com
|
Mr. Charles Kummeth
|
3,000 employees
NASDAQ | Healthcare | Biotechnology
Grifols, S.A.
Grifols, S.A. country of incorporation
|
https://www.grifols.com
|
Mr. Raimon Grifols Roura
|
27,584 employees
NASDAQ | Healthcare | Drug Manufacturers—General
Q123 reported Nov 7, 2022 Reporting Period
$269.66M 4.6% vs. Q122 Revenues Q123
66.6% 0.4% vs. Q122 Gross Profit Margin
33.21% 22.9% vs. Q122 Net Profit Margin
46.53M -3.9% vs. Q122 Free Cash Flow Q123
$0.55 30.6% vs. Q122 EPS Q123
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q123
0.11%
Q222
Q222 reported Jun 30, 2022 Reporting Period
$1.54B 14.1% vs. Q221 Revenues Q222
37.46% -12.8% vs. Q221 Gross Profit Margin
5.86% -42.2% vs. Q221 Net Profit Margin
88.81M -79.6% vs. Q221 Free Cash Flow Q222
$0.13 -34% vs. Q221 EPS Q222
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q123
0.11%
Q222
Ratios
As of
Sep 30, 2022
Dec 31, 2021
Quick Ratio
2.74
0.92
Current Ratio
4.01
1.59
Cash Ratio
1.2
0.19
Price to Book
6.36
1.11
Price to Sales
41.32
1.37
Price to Earnings
31.1
37.02